| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $46.3M | +6.6% | +40.5% |
| Cost of Revenue | $10.9M | +2.0% | +35.8% |
| Gross Profit | $35.4M | +8.0% | +42.0% |
| R&D Expense | $17.3M | +15.1% | +45.8% |
| SG&A Expense | $33.2M | +5.6% | +18.6% |
| Operating Income | -$15.1M | -10.1% | -1.1% |
| Pre-tax Income | -$50.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $291.2M | +263.0% | +350.3% |
| Accounts Receivable | $27.9M | -6.2% | — |
| Current Assets | $327.8M | +176.7% | — |
| Total Assets | $364.4M | +128.7% | — |
| Current Liabilities | $37.8M | +14.9% | — |
| Total Liabilities | $109.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$43.4M | — | — |
| Capital Expenditures | $3.1M | — | — |
| Investing Cash Flow | -$3.1M | — | — |
| Financing Cash Flow | $286.1M | — | — |
| Free Cash Flow | -$46.6M | — | — |
| -456.3% |
| -165.5% |
| Income Tax | $30K | -49.2% | — |
| Net Income | -$50.9M | -453.0% | -165.7% |
| EPS (Basic) | -$1.04 | +28.8% | +69.7% |
| EPS (Diluted) | -$1.04 | +28.8% | +69.7% |
| -61.5% |
| — |
| Stockholders' Equity | $254.6M | +128.4% | +130.6% |